Showing results (151-160 of 437) with videos related to
Sort By:
Pageof 44
Malaria Journal|February 21, 2024
Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trialChristian Kositz, Hristina Vasileva, Nuredin Mohammed, et al.Elife|September 27, 2021
Quantifying the relationship between SARS-CoV-2 viral load and infectiousnessAurélien Marc, Marion Kerioui, François Blanquart, et al.Frontiers in Oncology|July 14, 2020
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts OutcomeNicholas J W Easom, Michael Marks, Dawda Jobe, et al.International Journal of STD & AIDS|August 21, 2024
IUSTI Europe position statement on use of DoxyPEP: June 2024Jackie Sherrard, Deniz Gokengin, Andrew Winter, et al.Public Health|August 17, 2025
The impact of lifestyle on infection risks and mortality: a UK biobank cohort studyKarl Stattin, Bram Burger, Mikael Eriksson, et al.Plos Neglected Tropical Diseases|June 14, 2023
Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A reviewScott McPherson, Anthony W Solomon, Fikre Seife, et al.Plos Neglected Tropical Diseases|December 5, 2018
Prioritizing surveillance activities for certification of yaws eradication based on a review and model of historical case reportingChristopher Fitzpatrick, Kingsley Asiedu, Anthony W Solomon, et al.Plos Neglected Tropical Diseases|December 2, 2015
Long Term Control of Scabies Fifteen Years after an Intensive Treatment ProgrammeMichael Marks, Betty Taotao-Wini, Lorraine Satorara, et al.Lancet (London, England)|November 20, 2022
MonkeypoxOriol Mitjà, Dimie Ogoina, Boghuma K Titanji, et al.International Journal of Antimicrobial Agents|January 11, 2020
Clinical outcomes of teicoplanin use in the OPAT settingHannah Dabrowski, Helena Wickham, Surjo De, et al.Pageof 44